Literature DB >> 9227458

Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults.

N Vahl1, J O Jørgensen, C Skjaerbaek, J D Veldhuis, H Orskov, J S Christiansen.   

Abstract

We tested the hypothesis that body composition is the major predictor of growth hormone (GH) secretion in nonobese adults. We measured lean and fat tissue distribution (computerized tomography and dual-energy X-ray absorptiometry scan) and physical fitness [maximal oxygen consumption (Vo2max)] in 42 healthy nonobese adults (22 women and 20 men, age range 27-59 yr, mean +/- SE body mass index = 24 +/- 0.5 kg/m2). Deconvolution analysis was used to estimate specific features of 24-h GH secretion and clearance. Approximate entropy was used to quantify the regularity of GH release. Older subjects exhibited decreased estimates of GH secretion compared with younger subjects. Females had higher estimates of GH secretion, a longer GH half-life, and displayed more irregularity in GH release than males. Mean 24-h serum GH concentrations correlated inversely with intra-abdominal fat and waist-to-hip ratio and positively with Vo2max. Multiple linear regression analysis revealed intra-abdominal fat as the dominant determinant of estimates of GH secretion. Vo2max was more important than sex and age in predicting GH secretion. We conclude that abdominal fat is the major determinant of GH secretion in healthy nonobese adults. Although the underlying mechanisms remain elusive, our findings extend the clinical implications of visceral adiposity to include hyposomatotropism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9227458     DOI: 10.1152/ajpendo.1997.272.6.E1108

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  47 in total

1.  Diagnosis: a reappraisal of the diagnosis of growth hormone deficiency.

Authors:  Gudmundur Johannsson
Journal:  Nat Rev Endocrinol       Date:  2010-04       Impact factor: 43.330

2.  Determinants of IGF1 and GH across the weight spectrum: from anorexia nervosa to obesity.

Authors:  D J Brick; A V Gerweck; E Meenaghan; E A Lawson; M Misra; P Fazeli; W Johnson; A Klibanski; K K Miller
Journal:  Eur J Endocrinol       Date:  2010-05-25       Impact factor: 6.664

3.  Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial.

Authors:  Miriam A Bredella; Eleanor Lin; Danielle J Brick; Anu V Gerweck; Lindsey M Harrington; Martin Torriani; Bijoy J Thomas; David A Schoenfeld; Anne Breggia; Clifford J Rosen; Linda C Hemphill; Zida Wu; Nader Rifai; Andrea L Utz; Karen K Miller
Journal:  Eur J Endocrinol       Date:  2012-01-24       Impact factor: 6.664

4.  Determinants of dual secretagogue drive of burst-like growth hormone secretion in premenopausal women studied under a selective estradiol clamp.

Authors:  Dana Erickson; Daniel M Keenan; Leon Farhy; Kristi Mielke; Cyril Y Bowers; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2004-12-21       Impact factor: 5.958

Review 5.  Interactive regulation of postmenopausal growth hormone insulin-like growth factor axis by estrogen and growth hormone-releasing peptide-2.

Authors:  J D Veldhuis; W S Evans; C Y Bowers; S Anderson
Journal:  Endocrine       Date:  2001-02       Impact factor: 3.633

6.  Anthropometry, CT, and DXA as predictors of GH deficiency in premenopausal women: ROC curve analysis.

Authors:  Miriam A Bredella; Andrea L Utz; Martin Torriani; Bijoy Thomas; David A Schoenfeld; Karen K Miller
Journal:  J Appl Physiol (1985)       Date:  2008-12-18

Review 7.  Motivations and methods for analyzing pulsatile hormone secretion.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Steven M Pincus
Journal:  Endocr Rev       Date:  2008-10-21       Impact factor: 19.871

8.  Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: a randomized controlled trial.

Authors:  Hideo Makimura; Meghan N Feldpausch; Alison M Rope; Linda C Hemphill; Martin Torriani; Hang Lee; Steven K Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2012-09-26       Impact factor: 5.958

Review 9.  Pathophysiology of GHRH-growth hormone-IGF1 axis in HIV/AIDS.

Authors:  Shobhit Jain; Ninad Desai; Amrit Bhangoo
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

10.  Prevalence of pituitary hormone dysfunction, metabolic syndrome, and impaired quality of life in retired professional football players: a prospective study.

Authors:  Daniel F Kelly; Charlene Chaloner; Diana Evans; Amy Mathews; Pejman Cohan; Christina Wang; Ronald Swerdloff; Myung-Shin Sim; Jihey Lee; Mathew J Wright; Claudia Kernan; Garni Barkhoudarian; Kevin C J Yuen; Kevin Guskiewicz
Journal:  J Neurotrauma       Date:  2014-05-08       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.